Elite Pharmaceuticals, Inc.
USD0.38
-0.02 (-4.81%)
CEO
Nasrat Hakim
IPO Date
2000-02-24
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
OTC
Country
US
Open
$0.40
Prev. Close
$0.40
Day Low
$0.37
Day High
$0.45
52W Low
$0.33
52W High
$0.78
Market Cap
$0.40B
Volume
0.89M
| 2,500,000 |
| $0.03 |
| 3 Oct 2025 | Plassche Douglas | EVP Operations | S-Sale | Disposed | 800,000 | $0.62 |
| 26 Aug 2025 | ELITE PHARMACEUTICALS INC /NV/ | EVP Operations | S-Sale | Disposed | 500,000 | $0.52 |
| 26 Aug 2025 | ELITE PHARMACEUTICALS INC /NV/ | EVP Operations | M-Exempt | Acquired | 2,500,000 | $0.03 |
| 26 Aug 2025 | ELITE PHARMACEUTICALS INC /NV/ | EVP Operations | M-Exempt | Disposed | 2,500,000 | $0.03 |
| 25 Jul 2025 | Kirkov Kirko | Chief Commercial Officer | P-Purchase | Acquired | 16,366 | $0.59 |
| 10 Jul 2025 | Plassche Douglas | EVP Operations | S-Sale | Disposed | 200,000 | $0.58 |
| 8 Jul 2025 | Plassche Douglas | EVP Operations | M-Exempt | Acquired | 2,500,000 | $0.03 |
| 8 Jul 2025 | Plassche Douglas | EVP Operations | M-Exempt | Disposed | 2,500,000 | $0.03 |